The DOI matches its Crossref record.
Small-Molecule Inhibitors Specifically Targeting Type III Secretion
Open accessAbstract
The type III secretion (TTS) system is used by several animal and plant pathogens to deliver effector proteins into the cytosol of the eukaryotic target cell as a strategy to evade the defense reactions elicited by the infected organism. The fact that these systems are highly homologous implies that novel antibacterial agents that chemically attenuate the pathogens via a specific interaction with the type III secretion mechanism can be identified. A number of small organic molecules having this potential have recently been identified (A. M. Kauppi, R. Nordfelth, H. Uvell, H. Wolf-Watz, and M. Elofsson, Chem. Biol. 10:241-249, 2003). Using different reporter gene constructs, we showed that compounds that belong to a class of acylated hydrazones of different salicylaldehydes target the TTS system of Yersinia pseudotuberculosis . One of these compounds, compound 1, was studied in detail and was found to specifically block Yop effector secretion under in vitro conditions by targeting the TTS system. In this respect the drug mimics the well-known effect of calcium on Yop secretion. In addition, compound 1 inhibits Yop effector translocation after infection of HeLa cells without affecting the eukaryotic cells or the bacteria. A HeLa cell model that mimics in vivo conditions showed that compound 1 chemically attenuates the pathogen to the advantage of the eukaryotic cell. Thus, our results show proof of concept, i.e., that small compounds targeting the TTS system can be identified, and they point to the possible use of TTS inhibitors as a novel class of antibacterial agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Targeting virulence: a new paradigm for antimicrobial therapy
Clatworthy, A. E., Pierson, E., & Hung, D. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.24 · Cited by 1,406
Protein delivery into eukaryotic cells by type III secretion machines
Galán, J. E., & Wolf-Watz, H. (2006) · Nature · doi:10.1038/nature05272 · Cited by 1,041
Self-citationThe biology and future prospects of antivirulence therapies
Cegelski, L., Marshall, G. R., Eldridge, G. R., & Hultgren, S. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1818 · Cited by 788
Antibiotic alternatives: the substitution of antibiotics in animal husbandry?
Cheng, G., Hao, H., Xie, S., Wang, X., Dai, M., Huang, L., & Yuan, Z. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00217 · Cited by 622
Bacteria and host interactions in the gut epithelial barrier
Ashida, H., Ogawa, M., Kim, M., Mimuro, H., & Sasakawa, C. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.741 · Cited by 337
Metadata
- Authors
- Nordfelth, R., Kauppi, A. M., Norberg, H. A., Wolf-Watz, H., & Elofsson, M.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2005-05
- Volume
- 73
- Issue
- 5
- Pages
- 3104-3114
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2165524414
- Cited by
- 214
- References
- 0
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Small-Molecule Inhibitors Specifically Targeting Type III Secretion. https://app.cochat.ai/papers/10.1128/iai.73.5.3104-3114.2005
- The paper
- Nordfelth, R., Kauppi, A. M., Norberg, H. A., Wolf-Watz, H., & Elofsson, M. (2005). Small-Molecule Inhibitors Specifically Targeting Type III Secretion. Infection and Immunity. https://doi.org/10.1128/iai.73.5.3104-3114.2005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.